Population pharmacokinetics of piperacillin/tazobactam across the adult lifespan

M Hemmersbach-Miller, SJ Balevic, PL Winokur… - Clinical …, 2023 - Springer
Abstract Background and Objective Piperacillin/tazobactam is one of the most frequently
used antimicrobials in older adults. Using an opportunistic study design, we evaluated the …

Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling

M Suyagh, PS Collier, JS Millership… - …, 2011 - publications.aap.org
OBJECTIVES: To characterize the population pharmacokinetics of metronidazole in preterm
neonates. PATIENTS AND METHODS: Data were collected prospectively from 32 preterm …

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection

C Li, JL Kuti, CH Nightingale… - Journal of …, 2005 - academic.oup.com
Objectives: We investigated the population pharmacokinetics and pharmacodynamics of
piperacillin and tazobactam in hospitalized patients. Patients and methods: A multicentre …

Determination of population pharmacokinetic parameters for amikacin in neonates using mixed-effect models

JH Botha, MJ Du Preez, R Miller, M Adhikari - European journal of clinical …, 1998 - Springer
Objective: The population pharmacokinetics of amikacin, in neonates, was investigated
using the nonlinear mixed effects model (NONMEM). Methods: One hundred and six steady …

Oral and intravenous amoxicillin dosing recommendations in neonates: a pooled population pharmacokinetic study

FM Keij, S Schouwenburg, RF Kornelisse… - Clinical Infectious …, 2023 - academic.oup.com
Background There is a lack of evidence on oral amoxicillin pharmacokinetics and exposure
in neonates with possible serious bacterial infection (pSBI). We aimed to describe …

Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients

KM Shea, SC Cheatham, MF Wack, DW Smith… - International journal of …, 2009 - Elsevier
The objective of this study was to evaluate the steady-state pharmacokinetics and
pharmacodynamics of piperacillin/tazobactam, administered by prolonged infusion, in …

Preterm physiologically based pharmacokinetic model. Part II: applications of the model to predict drug pharmacokinetics in the preterm population

K Abduljalil, X Pan, A Pansari, M Jamei… - Clinical …, 2020 - Springer
Background Preterm neonates are usually not part of a traditional drug development
programme, however they are frequently administered medicines. Developing modelling …

Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.

J Wang, WQ Liang, JJ Wu, CM Pan - Acta pharmacologica Sinica, 2000 - europepmc.org
Aim To make programs for population pharmacokinetic analysis and to assess the ability of
this method in pharmacokinetic parameter estimation and in the prediction of serum …

Using a validated population pharmacokinetic model for dosing recommendations of continuous infusion piperacillin for critically ill adult patients

I El-Haffaf, R Guilhaumou, L Velly, A Marsot - Clinical Pharmacokinetics, 2022 - Springer
Abstract Background and Objective Piperacillin is a broad-spectrum β-lactam antibiotic
commonly prescribed in intensive care units. Many piperacillin population pharmacokinetic …

Microdialysis as a safe and feasible method to study target-site piperacillin-tazobactam disposition in septic piglets and children

E Hermans, M Devreese, M Zeitlinger, E Dhont… - International Journal of …, 2023 - Elsevier
Objectives Knowledge on the tissue penetration of piperacillin-tazobactam in children with
sepsis is lacking. In this study, the feasibility and performance of microdialysis experiments …